Direct Oral Anticoagulants: A User's Guide | Consultant360
Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea | Advances in Therapy
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
Switching from warfarin to NOAC. NOAC, non-vitamin K antagonist oral... | Download Scientific Diagram
Edoxaban switching scheme: worth the risks? - The Pharmaceutical Journal
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial - The Lancet
Replacing warfarin with a NOAC in patients on chronic anticoagulation therapy - The Hospitalist
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Impact of anticoagulants on the clinical outcomes of colonic diverticular bleeding comparing warfarin and direct oral anticoagulants | Scientific Reports
Figure 4 from European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation | Semantic Scholar
Assessing patient preferences for switching from warfarin to direct oral anticoagulants | Journal of Thrombosis and Thrombolysis
Direct Oral Anticoagulants for Secondary Stroke Prevention - Practical Neurology
cardio-met on X: "4) Treatment options for #VTE include initial use of heparin (usually low molecular weight heparin, #LMWH) overlapping with # warfarin, or initial LMWH switching to direct oral anticoagulant (#DOAC) or
Transition of Anticoagulants 2016
Direct Oral Anticoagulants (DOACs) | STROKE MANUAL
Warfarin to DOAC and DOAC to Warfarin Transitions Here ... | GrepMed
Anticoagulant Bridging • Switching from LMWH ... | GrepMed
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York
Switching between anticoagulant regimes; *half dose for edoxaban;... | Download Scientific Diagram
CorConsult Rx - #Repost @ambcarerx ・・・ Oral Anticoagulants have many chronic indications, most commonly VTE treatment/prophylaxis, atrial fibrillation, and valvular heart disease. VTE & AF can both be treated with either warfarin
Support for Switching from Warfarin to Direct-acting Oral Anticoagulants (DOACs) for patients with Non-Valvular - Atrial Fibrill
JCM | Free Full-Text | Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
K. thanavaro the indications and uses of the novel anticoagulants | PPT
Switching between the oral anticoagulants | Download Scientific Diagram
Jabchai Medicine - Switching between warfarin and NOACs . >> NOACS have rapid onset of action, when switch warfarin to NOAC, you can give NOACs if INR <2.5. >> Warfarin have late
Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety | Journal of the American College of Cardiology
